Physician profile
Moina Uddin
NPI 1902112188
$650.25
in general payments reported to CMS, 2019-2025
9 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.74 · 2023: $199 · 2024: $254 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $169.30 | 2023-2024 | Omnipod |
| Sanofi-Aventis U.S. LLC | $125.60 | 2024 | |
| Neurocrine Biosciences, INC. | $117.95 | 2025 | |
| Rhythm Pharmaceuticals, INC. | $112.88 | 2024 | Imcivree |
| Pfizer INC. | $45.06 | 2023-2025 | |
| Eton Pharmaceuticals, INC. | $21.99 | 2025 | Alkindi, Khindivi, Increlex |
| Arbor Pharmaceuticals, INC. | $21.84 | 2019 | |
| Abbvie INC. | $21.73 | 2023 | Lupron Depot |
| Ascensia Diabetes Care US INC. | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moina Uddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.